Clinical Trial Update: A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma [NA]

View source ↗

Summary

A completed clinical trial evaluating an amino acid mixture (Enterade) used during high-dose melphalan conditioning prior to autologous stem cell transplantatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Enterade

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Multiple Myeloma, Non-Hodgkin's Lymphoma | NA | Status: COMPLETED | Results posted: 2023-03-16